Annovis Bio Statistics

Total Valuation

Annovis Bio has a market cap or net worth of $39.95 million. The enterprise value is $17.71 million.

Market Cap	39.95M
Enterprise Value	17.71M

Important Dates

The next estimated earnings date is Thursday, August 14, 2025, before market open.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Annovis Bio has 19.49 million shares outstanding. The number of shares has increased by 44.17% in one year.

Current Share Class	19.49M
Shares Outstanding	19.49M
Shares Change (YoY)	+44.17%
Shares Change (QoQ)	+26.36%
Owned by Insiders (%)	14.69%
Owned by Institutions (%)	10.79%
Float	15.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.66
P/TBV Ratio	1.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.68

Current Ratio	10.68
Quick Ratio	8.88
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -280.78% and return on invested capital (ROIC) is -151.98%.

Return on Equity (ROE)	-280.78%
Return on Assets (ROA)	-91.05%
Return on Invested Capital (ROIC)	-151.98%
Return on Capital Employed (ROCE)	-103.86%
Revenue Per Employee	n/a
Profits Per Employee	-$1.94M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.22% in the last 52 weeks. The beta is 1.62, so Annovis Bio's price volatility has been higher than the market average.

Beta (5Y)	1.62
52-Week Price Change	-64.22%
50-Day Moving Average	2.11
200-Day Moving Average	4.46
Relative Strength Index (RSI)	41.10
Average Volume (20 Days)	615,669

Short Selling Information

The latest short interest is 2.21 million, so 11.32% of the outstanding shares have been sold short.

Short Interest	2.21M
Short Previous Month	1.96M
Short % of Shares Out	11.32%
Short % of Float	14.11%
Short Ratio (days to cover)	3.74

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.17M
Pretax Income	-47.53M
Net Income	-29.06M
EBITDA	n/a
EBIT	-25.17M
Earnings Per Share (EPS)	-$2.09

Full Income Statement

Balance Sheet

The company has $22.24 million in cash and n/a in debt, giving a net cash position of $22.24 million or $1.14 per share.

Cash & Cash Equivalents	22.24M
Total Debt	n/a
Net Cash	22.24M
Net Cash Per Share	$1.14
Equity (Book Value)	24.05M
Book Value Per Share	1.23
Working Capital	24.23M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-22.96M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Annovis Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-44.17%
Shareholder Yield	-44.17%
Earnings Yield	-72.75%
FCF Yield	n/a

Analyst Forecast

The average price target for Annovis Bio is $30.25, which is 1,354.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.25
Price Target Difference	1,354.33%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2